VIA
SANA icon

Virtus Investment Advisers’s Sana Biotechnology SANA Stock Holding History

Virtus Investment Advisers’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$426K Buy
122,089
+69,037
+130% +$222K 0.1% 244
2026
Q1 		$153K Buy
53,052
+1,296
+3% +$5.11K 0.04% 442
2025
Q4 		$211K Buy
51,756
+6,958
+16% +$31.2K 0.06% 366
2025
Q3 		$159K Buy
44,798
+7,777
+21% +$28.1K 0.05% 365
2025
Q2 		$101K Sell
37,021
-43,446
-54% -$89.6K 0.03% 329
2025
Q1 		$135K Buy
+80,467
New +$225K 0.04% 365

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Virtus Investment Advisers's SANA Position: Q2 2026 in Review

Virtus Investment Advisers increased its Sana Biotechnology (SANA) stake by 130% in Q2 2026, buying an estimated $222K and bringing the position to 122,089 shares worth $426K. The position accounts for 0.1% of the portfolio, ranked #244.

Virtus Investment Advisers first reported a position in SANA in Q1 2025 and has held it in 6 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Virtus Investment Advisers held 122,089 shares of Sana Biotechnology worth $426K as of Q2 2026.
  • Virtus Investment Advisers bought 69,037 Sana Biotechnology shares in Q2 2026, an estimated $222K.
  • Sana Biotechnology made up 0.1% of Virtus Investment Advisers's portfolio in Q2 2026, its #244 holding.
  • Virtus Investment Advisers first reported a position in Sana Biotechnology in Q1 2025 and has held it in 6 quarters since.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.